Seegene Launches Industry's First Global Million Clinical Study to Shape New Disease-Specific Testing Standards

Summary

Seegene launched the Global Million Clinical Study encompassing one million test cases to evaluate the clinical utility of syndromic PCR testing and establish disease-specific testing standards. The study aims to generate real-world scientific evidence supporting diagnostic approaches.